Spaulding Clinical Receives FDA 510(k) Clearance for 12-Lead ECG Device

Press Release:

Spaulding Electrocardiograph 2100iQ

Spaulding Medical, LLC announced the FDA 510(k) Clearance for their newest 12-Lead ECG device - the Spaulding Electrocardiograph 2100iQ™.

The wireless, hand-held cardiac safety medical device was designed to streamline and improve the collection of real-time data of ECG data via Bluetooth™ for doctors and patients. 

Managed entirely in the Cloud, the Spaulding Electorcardiograph 2100iQ™ mission is to deliver high-quality data in less time and at a reduced cost.

With the FDA 510(k) Clearance ready, Spaulding Clinical Research, LLC has strengthened their commitment to being an innovation leader in cardiac safety solutions.

 

Read Full Press Release >>

MEET US @ DIA 2016

Dia - Develop Innovate Advance 2016 banner
 
27-29 June 2016     //     Philadelphia, PA     //     Booth #2327
 
Spaulding Clinical Research, LLC invites you to meet us at DIA 2016 and learn how our paperless, 200-Bed Phase I Clinic and innovative ECG Core Laboratory technology can accelerate your drug's development.
 
Meet us @ Booth #2327 and ask about:
 
1)  Our company's 2015 performance Metrics
2)  How we can reduce site burden and the cost of your study with our latest Cardiac Safety Solution.  Here's a teaser:  View Press Release >>
 
If you can't make the event, make sure to check out some of our latest content:
 
 
If you are attending DIA 2016 and would like to schedule a meeting, please This email address is being protected from spambots. You need JavaScript enabled to view it. or call us at 1-262-334-6020.
 

Meet Us @ OCT East Coast 2016

Outsourcing in Clinical East Coast 2016

25-26 May 2016     //     King of Prussia, PA

Spaulding Clinical Research, LLC invites you to meet with Chad Pollio (Director of Business Development) and learn how our paperless, 200-Bed Phase I Clinic and innovative ECG Core Laboratory technology can accelerate your drug's development.

Make sure to ask Chad about:

1)  Our company's 2015 performance Metrics
2)  A live demo of the latest ECG Core Lab Technology

If you can't make the event, make sure to check out some of our latest content:

1)  "Characterizing QT Effect in Early Phase Oncology/Patient Studies - A New Approach"
2)  "Evaluating the Effectiveness of a Thorough QT Assessment Program"

If you are attending Outsourcing in Clinical Trials East Coast 2016 and would like to schedule a meeting with Chad, please This email address is being protected from spambots. You need JavaScript enabled to view it. or call us at 1-262-334-6020.  Learn More.